These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
651 related articles for article (PubMed ID: 18368636)
1. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme. Malila N; Oivanen T; Hakama M Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636 [TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004. Malila N; Anttila A; Hakama M J Med Screen; 2005; 12(1):28-32. PubMed ID: 15814016 [TBL] [Abstract][Full Text] [Related]
3. Coverage and performance of colorectal cancer screening with the faecal occult blood test in Finland. Malila N; Palva T; Malminiemi O; Paimela H; Anttila A; Hakulinen T; Järvinen H; Kotisaari ML; Pikkarainen P; Rautalahti M; Sankila R; Vertio H; Hakama M J Med Screen; 2011; 18(1):18-23. PubMed ID: 21536812 [TBL] [Abstract][Full Text] [Related]
4. Colorectal screening in Germany. Pox C; Schmiegel W Z Gastroenterol; 2008 Apr; 46 Suppl 1():S31-2. PubMed ID: 18368638 [No Abstract] [Full Text] [Related]
5. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589 [TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer screening in the Czech Republic. Zavoral M Z Gastroenterol; 2008 Apr; 46 Suppl 1():S29-30. PubMed ID: 18368637 [TBL] [Abstract][Full Text] [Related]
7. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK; J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952 [TBL] [Abstract][Full Text] [Related]
8. A 25-year follow-up of a population screened with faecal occult blood test in Finland. Malila N; Hakama M; Pukkala E Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857 [TBL] [Abstract][Full Text] [Related]
9. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer. Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181 [TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer mass screening event utilising quantitative faecal occult blood test. Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676 [TBL] [Abstract][Full Text] [Related]
11. Colonoscopy: a review of its yield for cancers and adenomas by indication. Rex DK Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270 [TBL] [Abstract][Full Text] [Related]
12. Early detection of colorectal cancer with faecal occult blood test screening. Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855 [TBL] [Abstract][Full Text] [Related]
13. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence. Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M; J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257 [TBL] [Abstract][Full Text] [Related]
14. French colorectal cancer screening pilot programme: results of the first round. Goulard H; Boussac-Zarebska M; Ancelle-Park R; Bloch J J Med Screen; 2008; 15(3):143-8. PubMed ID: 18927097 [TBL] [Abstract][Full Text] [Related]
15. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance. Manfredi S; Piette C; Durand G; Plihon G; Mallard G; Bretagne JF Endoscopy; 2008 May; 40(5):422-7. PubMed ID: 18231963 [TBL] [Abstract][Full Text] [Related]
16. Limitations of the faecal occult blood test in screening for colorectal cancer. Delcò F; Sonnenberg A Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196 [TBL] [Abstract][Full Text] [Related]
17. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy. Brenner H; Haug U; Arndt V; Stegmaier C; Altenhofen L; Hoffmeister M Gastroenterology; 2010 Mar; 138(3):870-6. PubMed ID: 19909750 [TBL] [Abstract][Full Text] [Related]
18. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Segnan N; Senore C; Andreoni B; Azzoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; Ederle A; Fantin A; Ferrari A; Fracchia M; Ferrero F; Gasperoni S; Recchia S; Risio M; Rubeca T; Saracco G; Zappa M; Gastroenterology; 2007 Jun; 132(7):2304-12. PubMed ID: 17570205 [TBL] [Abstract][Full Text] [Related]
19. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Kronborg O; Jørgensen OD; Fenger C; Rasmussen M Scand J Gastroenterol; 2004 Sep; 39(9):846-51. PubMed ID: 15513382 [TBL] [Abstract][Full Text] [Related]